Bank of Montreal
BXRX

Bank of Montreal’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Bank of Montreal’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Hold
0
– – – 5405
2021
Q1 		– Hold
0
– – – 5462
2020
Q4 		– Hold
0
– – – 5198
2020
Q3 		– Hold
0
– – – 5007
2020
Q2 		– Hold
0
– – – 4918
2020
Q1 		– Sell
-1
Closed -$9.44K – 4964
2019
Q4 		$7K Buy
+1
New +$8.53K ﹤0.01% 4650

Other funds holding BXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Bank of Montreal's BXRX Position: Q2 2021 in Review

Bank of Montreal held its Baudax Bio, Inc. Common Stock (BXRX) position steady in Q2 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5405.

Bank of Montreal first reported a position in BXRX in Q4 2019 and has held it in 1 quarter since. The position peaked at $7K in Q4 2019. 31 funds tracked by Wall St. Rank hold BXRX as of Q2 2021.

  • Bank of Montreal held 0 shares of Baudax Bio, Inc. Common Stock worth $0 as of Q2 2021.
  • Bank of Montreal left its Baudax Bio, Inc. Common Stock share count unchanged in Q2 2021.
  • Baudax Bio, Inc. Common Stock made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2021, its #5405 holding.
  • Bank of Montreal first reported a position in Baudax Bio, Inc. Common Stock in Q4 2019 and has held it in 1 quarter since.
  • Bank of Montreal's Baudax Bio, Inc. Common Stock position peaked at $7K in Q4 2019.
  • 31 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.